posted May 29, 2022 12:04 pm by Joe455
(24016)
A little fresh blood in management is good.
rate and reply
posted January 31, 2022 08:39 am by AwareInvestor
(504)
Biogen Inc appears to be facing issues related to its executive team. The firm this morning indicated that two long time directors of the company will be retiring from their positions. The retirements
...read more
posted June 12, 2021 11:51 pm by TinToronto
(67)
They fail to mention the brain lesions, edema, and bleeding that this drug causes. They fail to mention that the average AD patient will be able to afford ongoing treatment of this drug due to
...read more
posted June 09, 2021 08:47 am by AviseAnalytics
(4)
BIOGEN SCORES A BIG WIN FOR ADUHELM™, BUT THE PATH AHEAD ISN’T EASY!
rate and reply